CD70 and cancer: To check whether the cancer microenvironment harbored factors that could influence Th17 subpopulations, we evaluated the mRNA levels of CD70 (the CD27 ligand), IL‐6, and TGF‐β1 in the lysates of cancer nodules and spleens.